Back to search

University of Sheffield

Process and Formulation Optimization of a Continuous Microfluidic-Based Platform for High-Quality mRNA-LNP Production

Abstract

dc:description.abstract

Messenger RNA (mRNA) has emerged as a transformative platform for vaccines and targeted therapies due to its capacity for precise and rapid gene expression. The COVID-19 pandemic underscored both its promise and the challenges of large-scale production. In response, continuous flow manufacturing—guided by Quality by Design (QbD) principles and enabled by automation and digital technologies—offers a scalable, consistent, and efficient alternative to traditional batch production.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Yang, Zidi
Advisor dc:contributor.advisor
  • Kis, Zoltan

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Yang, Zidi. Process and Formulation Optimization of a Continuous Microfluidic-Based Platform for High-Quality mRNA-LNP Production. doctoral thesis, University of Sheffield, 2025.